StreetAlpha
13F holdings · Q3 2026

325 Capital

New York, NY · files as 325 Capital LLC
Know the moment 325 Capital filesYou follow 325 Capital An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1873893

325 Capital reported 12 stocks worth $350M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are MGNI (24.6%), ASTH (16.4%) and APEI (14.3%).

Latest filing: what 325 Capital did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
0 new0 added0 trimmed0 sold outBought about $0 · sold about $0
New 0

None

Added 0

None

Trimmed 0

None

Sold out 0

None

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$350M−16.6% vs last quarter
Stocks held120 new · 0 sold out
Top 5 weight76.1%very concentrated
Turnover0%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
MGNI
Magnite Inc
$86.2M24.6%3.4MNo change5 of 8
2
ASTH
Astrana Health Inc
$57.4M16.4%1.6MNo change8 of 8
3
APEI
American Pub ED Inc
$49.9M14.3%1.2MNo change8 of 8
4
BLBD
Blue Bird Corp
$39.5M11.3%711KNo change8 of 8
5
SPIR
Spire Global Inc
$33.2M9.5%3MNo change7 of 8
6
MPAA
Motorcar Pts Amer Inc
$21.2M6.0%2MNo change8 of 8
7
LFCR
Lifecore Biomedical Inc
$19.1M5.5%2.9MNo change8 of 8
8
AIOT
Powerfleet Inc
$15M4.3%5.3MNo change8 of 8
9
DBD
Diebold Nixdorf Inc
$14.8M4.2%242KNo change4 of 8
10
BTMD
Biote Corp
$5.5M1.6%4.5MNo change8 of 8
🔒 2 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Reported value

last 8 quarters
$259MQ4 '24
$241MQ1 '25
$253MQ2 '25
$329MQ3 '25
$285MQ4 '25
$274MQ1 '26
$419MQ2 '26
$350MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

325 Capital 13F FAQ

What does 325 Capital own?

325 Capital reported 12 stocks worth $350M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are MGNI (24.6%), ASTH (16.4%) and APEI (14.3%). The table above lists every position in the filing (the top 10 without an account).

What did 325 Capital buy and sell in Q3 2026?

Compared with Q2 2026: 0 new positions, 0 added to, 0 trimmed and 0 sold out.

When will 325 Capital file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is 325 Capital's portfolio worth?

The Q3 2026 filing reports $350M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.